Form 4: TELA Bio, Inc. Executive Paul Talmo Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Chief Technology Officer Paul Talmo of TELA Bio, Inc. reports a transaction involving common stock related to tax withholding upon vesting of restricted stock units.
Summary
- On March 31, 2024, Paul Talmo, Chief Technology Officer of TELA Bio, Inc., had 190 shares of common stock disposed of to cover withholding taxes.
- The transaction occurred at a price of $5.67 per share.
- Following the transaction, Talmo directly owns 68,860 shares of TELA Bio, Inc. common stock.
Sentiment
Score: 5
Explanation: This Form 4 filing is a routine disclosure of an insider transaction related to tax obligations. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This is a routine filing related to insider transactions, specifically the disposal of shares to cover tax obligations upon vesting of restricted stock units, which is a common practice among company executives.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares disposed of to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction involving the disposal of common stock. |
| 04/02/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.